PL2523969T3 - Szczep gospodarza bakteryjnego eksprymujący rekombinowany dsbc i mający zmniejszoną aktywność tsp - Google Patents

Szczep gospodarza bakteryjnego eksprymujący rekombinowany dsbc i mający zmniejszoną aktywność tsp

Info

Publication number
PL2523969T3
PL2523969T3 PL11701045T PL11701045T PL2523969T3 PL 2523969 T3 PL2523969 T3 PL 2523969T3 PL 11701045 T PL11701045 T PL 11701045T PL 11701045 T PL11701045 T PL 11701045T PL 2523969 T3 PL2523969 T3 PL 2523969T3
Authority
PL
Poland
Prior art keywords
bacterial host
host strain
expressing recombinant
strain expressing
recombinant dsbc
Prior art date
Application number
PL11701045T
Other languages
English (en)
Inventor
Mark Ellis
David Paul Humphreys
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of PL2523969T3 publication Critical patent/PL2523969T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241Tumor Necrosis Factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y503/00Intramolecular oxidoreductases (5.3)
    • C12Y503/04Intramolecular oxidoreductases (5.3) transposing S-S bonds (5.3.4)
    • C12Y503/04001Protein disulfide-isomerase (5.3.4.1), i.e. disufide bond-forming enzyme
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55Fab or Fab'

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL11701045T 2010-01-14 2011-01-13 Szczep gospodarza bakteryjnego eksprymujący rekombinowany dsbc i mający zmniejszoną aktywność tsp PL2523969T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1000591.6A GB201000591D0 (en) 2010-01-14 2010-01-14 Bacterial hoist strain

Publications (1)

Publication Number Publication Date
PL2523969T3 true PL2523969T3 (pl) 2017-09-29

Family

ID=42028361

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11701045T PL2523969T3 (pl) 2010-01-14 2011-01-13 Szczep gospodarza bakteryjnego eksprymujący rekombinowany dsbc i mający zmniejszoną aktywność tsp

Country Status (23)

Country Link
US (2) US8969038B2 (pl)
EP (1) EP2523969B1 (pl)
JP (1) JP5960608B2 (pl)
KR (1) KR101729361B1 (pl)
CN (2) CN102712679B (pl)
AU (2) AU2011206587A1 (pl)
CA (1) CA2786336C (pl)
CY (1) CY1118990T1 (pl)
DK (1) DK2523969T3 (pl)
ES (1) ES2627826T3 (pl)
GB (1) GB201000591D0 (pl)
HK (1) HK1206785A1 (pl)
HR (1) HRP20170852T1 (pl)
HU (1) HUE033555T2 (pl)
LT (1) LT2523969T (pl)
ME (1) ME02752B (pl)
PL (1) PL2523969T3 (pl)
PT (1) PT2523969T (pl)
RS (1) RS56159B1 (pl)
SG (1) SG182280A1 (pl)
SI (1) SI2523969T1 (pl)
SM (1) SMT201700295T1 (pl)
WO (1) WO2011086139A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2993231T1 (sl) 2009-09-24 2018-10-30 Ucb Biopharma Sprl Bakterijski sev za izražanje rekombinantnega proteina, ki ima proteazno deficientno DEGP-zadrževalno šaperonsko aktivnost, ter onesposobljena gena TSP in PTR
GB201000590D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000591D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201012599D0 (en) * 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
EP2546267A1 (en) * 2011-07-13 2013-01-16 UCB Pharma S.A. Bacterial host strain expressing recombinant DsbC
WO2013007388A1 (en) * 2011-07-13 2013-01-17 Ucb Pharma, S.A. Bacterial host strain expressing recombinant dsbc
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
US10563225B2 (en) * 2013-07-26 2020-02-18 President And Fellows Of Harvard College Genome engineering
JP6807327B2 (ja) 2014-12-22 2021-01-06 ユーシービー バイオファルマ エスアールエル タンパク質製造
BR112018015259A2 (pt) 2016-01-27 2018-12-18 Medimmune Llc métodos para preparação de anticorpos com um padrão de glicosilação definido
EP4467565A3 (en) 2016-12-21 2025-03-12 Amgen Inc. Anti-tnf alpha antibody formulations
EP3774926A1 (en) 2018-04-05 2021-02-17 Bio-Rad ABD Serotec GmbH Display systems for proteins of interest
AU2019375413A1 (en) * 2018-11-05 2021-05-27 Genentech, Inc. Methods of producing two chain proteins in prokaryotic host cells
AU2020243460A1 (en) 2019-03-18 2021-10-07 Bio-Rad Abd Serotec Gmbh Protection of SpyTag-containing periplasmic fusion proteins from protease Tsp and ompT degradation
CN114829578B (zh) * 2019-08-05 2024-09-24 瓦克化学股份公司 用于在发酵方法中释放重组蛋白的细菌菌株

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508192A (en) 1990-11-09 1996-04-16 Board Of Regents, The University Of Texas System Bacterial host strains for producing proteolytically sensitive polypeptides
US5264365A (en) 1990-11-09 1993-11-23 Board Of Regents, The University Of Texas System Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US5304472A (en) 1992-11-20 1994-04-19 Genentech, Inc. Method of controlling polypeptide production in bacterial cells
US5639635A (en) 1994-11-03 1997-06-17 Genentech, Inc. Process for bacterial production of polypeptides
US6027888A (en) 1996-04-05 2000-02-22 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells
US6083715A (en) 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
JP2000083670A (ja) 1998-09-09 2000-03-28 Hsp Kenkyusho:Kk DsbA/DsbB/DsbC/DsbD発現プラスミド
ATE343790T1 (de) 1999-06-29 2006-11-15 Siga Technologies Inc Test für degp-protease inhibitoren
GB0006398D0 (en) 2000-03-16 2000-05-03 Novartis Ag Organic compounds
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
AU8867501A (en) 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
AU2001287040A1 (en) 2000-09-01 2002-03-13 Biogen, Inc. Methods of designing and producing novel compounds having improved binding affinity for cd154 or other trimeric proteins
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
CZ304484B6 (cs) 2000-12-14 2014-05-21 Genentech, Inc. Bakteriální hostitelské kmeny a způsob tvorby polypeptidu
EP1356052B1 (en) * 2000-12-14 2008-08-20 Genentech, Inc. Production of full antibodies in procaryotic cells
TWI327597B (en) 2001-08-01 2010-07-21 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
ATE382053T1 (de) 2001-08-27 2008-01-15 Genentech Inc System zur antikörperexpression und- synthese
GB0124317D0 (en) 2001-10-10 2001-11-28 Celltech R&D Ltd Biological products
DE60230918D1 (de) 2001-11-16 2009-03-05 Biogen Idec Inc Polycistronische expression von antikörpern in cho zellen
GB0129105D0 (en) 2001-12-05 2002-01-23 Celltech R&D Ltd Expression control using variable intergenic sequences
AU2003244817B2 (en) 2002-06-28 2010-08-26 Domantis Limited Antigen-binding immunoglobulin single variable domains and dual-specific constructs
GB0224082D0 (en) 2002-10-16 2002-11-27 Celltech R&D Ltd Biological products
US7608429B2 (en) 2002-10-31 2009-10-27 Genentech, Inc. Methods and compositions for increasing antibody production
PT1570267E (pt) 2002-12-03 2012-01-03 Ucb Pharma Sa Ensaio para a identificação de células produtoras de anticorpos
GB0303337D0 (en) 2003-02-13 2003-03-19 Celltech R&D Ltd Biological products
NZ544486A (en) 2003-06-13 2009-04-30 Biogen Idec Inc Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof
DE602004017726D1 (de) 2003-06-30 2008-12-24 Domantis Ltd Pegylierte Single-domain-antikörper (dAb)
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
NZ580688A (en) 2003-07-26 2012-03-30 Biogen Idec Inc Method of designing altered antibodies having improved antigen-binding affinity
JP5102028B2 (ja) 2004-07-26 2012-12-19 バイオジェン・アイデック・エムエイ・インコーポレイテッド 抗cd154抗体
AU2005282700A1 (en) * 2004-09-02 2006-03-16 Genentech, Inc. Heteromultimeric molecules
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
GB0520169D0 (en) 2005-10-04 2005-11-09 Celltech R&D Ltd Biological products
EP2125894B1 (en) 2007-03-22 2018-12-19 Biogen MA Inc. Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
US7662587B1 (en) 2009-03-05 2010-02-16 E. I. Du Pont De Nemours And Company Gene knockout mutations that increase peptide production
SI2993231T1 (sl) 2009-09-24 2018-10-30 Ucb Biopharma Sprl Bakterijski sev za izražanje rekombinantnega proteina, ki ima proteazno deficientno DEGP-zadrževalno šaperonsko aktivnost, ter onesposobljena gena TSP in PTR
US8470552B2 (en) 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
MX2012005168A (es) 2009-11-05 2012-06-08 Genentech Inc Metodos y composicion para secrecion de polipeptidos heterologos.
GB201000588D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000591D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
EP2546267A1 (en) 2011-07-13 2013-01-16 UCB Pharma S.A. Bacterial host strain expressing recombinant DsbC
WO2013007388A1 (en) 2011-07-13 2013-01-17 Ucb Pharma, S.A. Bacterial host strain expressing recombinant dsbc
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product

Also Published As

Publication number Publication date
AU2011206587A1 (en) 2012-07-19
KR101729361B1 (ko) 2017-04-21
US20120288894A1 (en) 2012-11-15
ES2627826T3 (es) 2017-07-31
CA2786336A1 (en) 2011-07-21
DK2523969T3 (en) 2017-06-12
EP2523969A1 (en) 2012-11-21
JP2013516966A (ja) 2013-05-16
GB201000591D0 (en) 2010-03-03
ME02752B (me) 2018-01-20
SG182280A1 (en) 2012-08-30
AU2017202434B2 (en) 2019-05-16
US20150166652A1 (en) 2015-06-18
EP2523969B1 (en) 2017-03-22
US9493559B2 (en) 2016-11-15
KR20120115997A (ko) 2012-10-19
HUE033555T2 (hu) 2017-12-28
SI2523969T1 (sl) 2017-07-31
CN104328079A (zh) 2015-02-04
SMT201700295T1 (it) 2017-07-18
WO2011086139A1 (en) 2011-07-21
HRP20170852T1 (hr) 2017-08-25
RS56159B1 (sr) 2017-11-30
CN102712679B (zh) 2015-06-03
CY1118990T1 (el) 2018-01-10
LT2523969T (lt) 2017-06-26
BR112012016808A2 (pt) 2017-06-27
HK1206785A1 (en) 2016-01-15
JP5960608B2 (ja) 2016-08-02
CA2786336C (en) 2018-09-04
AU2017202434A1 (en) 2017-05-04
US8969038B2 (en) 2015-03-03
HK1176943A1 (en) 2013-08-09
PT2523969T (pt) 2017-07-04
CN102712679A (zh) 2012-10-03

Similar Documents

Publication Publication Date Title
SI2523969T1 (sl) Bakterijski gostiteljski sev, ki izraža rekombinantni DSBC in ima zmanjšano aktivost TSP
IL229947B (en) A bacterial host strain expressing recombinant dsbc
ZA201300147B (en) Recombinant host cells comprising phosphoketolases
SI2524043T1 (sl) Bakterijski gostiteljski sev, ki obsega mutantni gen spr in ima zmanjšano aktivnost Tsp
EP2569712A4 (en) Control system user interface
EP2569436B8 (en) Recombinant hcmv and rhcmv vectors and uses thereof
GB2494792B (en) Subsea orientation and control system
GB2480940B (en) Well control systems and methods
HUE041301T2 (hu) Fermentációs folyamatok és melléktermékek fejlesztése
SG10201503428RA (en) Data Gathering System
EP2531099A4 (en) Data gathering system
PT2523975T (pt) Estirpe hospedeira bacteriana compreendendo um gene spr mutante e um gene tsp de tipo selvagem
SG10201606462WA (en) Bacterial host strain
EP2551757A4 (en) INFORMATION INTERACTION PROCEDURE AND INTERFACE CONTROL SYSTEM
AU2011233911A1 (en) Dishwasher and control method thereof
EP2612298A4 (en) Co-compression and co-decompression of data values
AU2010100054A4 (en) Mattress Shredder
EP2540175A4 (en) Soft and elastic jacket
GB201000589D0 (en) Bacterial host strain
GB201000605D0 (en) Bacterial host strain
GB0916822D0 (en) Bacterial host strain
GB0916821D0 (en) Bacterial host strain
GB0916817D0 (en) Bacterial host strain
GB0916818D0 (en) Bacterial host strain
GB0922070D0 (en) Improved product assembly system and control software